1. CXCR2 inhibition overcomes ponatinib intolerance by eradicating chronic myeloid leukemic stem cells through PI3K/Akt/mTOR and dipeptidylpeptidase Ⅳ (CD26)
   Ji-Hea Kim et al, 2023, Heliyon CrossRef
2. MicroRNAs regulating SOX2 in cancer progression and therapy response
   Sepideh Mirzaei et al, 2021, Expert Reviews in Molecular Medicine CrossRef